skip to Main Content
The smarter way
to do assignments.

Please note that this is just a preview of a school assignment posted on our website by one of our clients. If you need assistance with this question too, please click on the Order button at the bottom of the page to get started.

You are the Director of Regulatory Affairs for a company that is developing a recombinant monoclonal antibody for the treatment of cancer. Describe the regulatory lifecycle of your drug (feel free to give it a name) including pre-clinical development, clinical testing, application for licensure, and post-marketing activities. Provide a general overview of each stage of the process, and be sure to address the following:
What pre-clinical characterization of the drug should be done?
What interactions with the FDA are necessary at each stage of development (e.g. formal meetings, applications, annual reports etc.)
What are the phases of clinical testing, and what is the purpose of each phase? How many patients are involved at each stage (generally)?
At what point(s) in the process do fees need to be paid to the FDA (as per the Prescription Drug User Fee Act (PDUFA))?
How is this process different if your drug is granted Orphan Drug status? Breakthrough Drug status?
What sections in the Code of Federal Regulations (21 CFR) apply to each stage of development for this particular type of product?
Please Include citations in APA style

GET HELP WITH THIS ASSIGNMENT TODAY

Clicking on this button will take you to our custom assignment page. Here you can fill out all the additional details for this particular paper (grading rubric, academic style, number of sources etc), after which your paper will get assigned to a course-specific writer. If you have any issues/concerns, please don’t hesitate to contact our live support team or email us right away.

How It Works        |        About Us       |       Contact Us

© 2018 | Intelli Essays Homework Service®

Back To Top